(Q46879661)

26 December 2017

title

Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge (English)

1 reference

26 December 2017

10

Hansel TT

1 reference

26 December 2017

author name string

Erin EM

1

1 reference

26 December 2017

Zacharasiewicz AS

2

1 reference

26 December 2017

Nicholson GC

3

1 reference

26 December 2017

Tan AJ

4

1 reference

26 December 2017

Higgins LA

5

1 reference

26 December 2017

Williams TJ

6

1 reference

26 December 2017

Murdoch RD

7

1 reference

26 December 2017

Durham SR

8

1 reference

26 December 2017

Barnes PJ

9

1 reference

26 December 2017

publication date

1 December 2005

1 reference

26 December 2017

Clinical & Experimental Allergy

published in

1 reference

26 December 2017

volume

35

1 reference

26 December 2017

issue

12

1 reference

26 December 2017

page(s)

1608-1614

1 reference

26 December 2017

The role of T lymphocytes in the pathogenesis of asthma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Chemokines in asthma: cooperative interaction between chemokines and IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Chemokines: roles in leukocyte development, trafficking, and effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Peptide immunotherapy for allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Cytokine-directed therapies for the treatment of chronic airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Preventive treatment of intranasal fluticasone propionate reduces cytokine mRNA expressing cells before and during a single nasal allergen provocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Omalizumab inhibits allergen challenge-induced nasal response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Chemokines induce eosinophil degranulation through CCR-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

IL-5-induced airway eosinophilia--the key to asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

A critical role for eosinophils in allergic airways remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Defining a link with asthma in mice congenitally deficient in eosinophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Biomedicine. Eosinophils in asthma: remodeling a tangled tale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

IL-13 receptors and signaling pathways: An evolving web

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Inhibition of Th2 differentiation and GATA-3 expression by BCL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2005.02381.X

10.1111/J.1365-2222.2005.02381.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

16393327

1 reference

26 December 2017